E-LIB Suche - Ergebnisse für: Texido, G.

1

NMS-173, a potent, covalent second generation IDH1/IDH2 inh..:

Magnaghi, P. ; Casuscelli, F. ; Ardini, E....
European Journal of Cancer. 174 (2022) - p. S17 , 2022

Link: https://doi.org/10.1016/..

2

NMS-P088, a CSF-1R, FLT3 and KIT inhibitor with outstanding..:

Ardini, E. ; Lombardi Borgia, A. ; Texido, G....
European Journal of Cancer. 69 (2016) - p. S127-S128 , 2016

Link: https://doi.org/10.1016/..

3

31 N-Myc amplification sensitizes tumor cells to inhibition..:

Carpinelli, P. ; Ceruti, R. ; Alzani, R....
European Journal of Cancer. 50 (2014) - p. 16 , 2014

Link: https://doi.org/10.1016/..

4

363 POSTER In vitro and in vivo molecular characterization ..:

Carpinelli, P. ; Ceruti, R. ; Degrassi, A....
European Journal of Cancer Supplements. 4 (2006) 12 - p. 112 , 2006

Link: https://doi.org/10.1016/..

5

Immunoglobulin E-binding site in Fc epsilon receptor (Fc ep..:

Bettler, B ; Texido, G ; Raggini, S..
Journal of Biological Chemistry. 267 (1992) 1 - p. 185-191 , 1992

Link: https://doi.org/10.1016/..

6

544 Characterization of Potent and Well Tolerated Second Ge..:

Ciomei, M. ; Amboldi, N. ; Cribioli, S....
European Journal of Cancer. 48 (2012) - p. 167 , 2012

Link: https://doi.org/10.1016/..

7

The polo-like kinase 1 (PLK1) inhibitor NMS-P937 is effecti..:

Casolaro, A ; Golay, J ; Albanese, C...
https://eprints.gla.ac.uk/80547/1/80547.pdf. , 2013

Link: https://eprints.gla.ac.u..

8

Impaired cerebral cortex development and blood pressure reg..:

Dono, R ; Texido, G ; Dussel, R..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1170755. , 1998

Link: http://www.ncbi.nlm.nih...

9

Mifepristone 2.5 mg versus 5 mg daily in the treatment of l..:

Carbonell Esteve JL ; Riverón AM ; Cano M...
http://www.dovepress.com/mifepristone-25-mg-versus-5-mg-daily-in-the-treatment-of-leiomyoma-bef-a9466. , 2012

Link: https://doaj.org/article..